Suppr超能文献

HSV 角膜炎角膜移植成功率:系统评价。

Corneal Graft Success Rates in HSV Keratitis: A Systematic Review.

机构信息

Department of Ophthalmology, University Hospital of Alexandroupolis, Dragana, Alexandroupolis, Greece.

出版信息

Acta Medica (Hradec Kralove). 2020;63(4):150-158. doi: 10.14712/18059694.2020.57.

Abstract

Herpes Simplex Virus (HSV) has worldwide prevalence. The primary objective of this systematic review was to compare penetrating keratoplasty (PK) and deep anterior lamellar keratoplasty (DALK) regarding the efficacy and complications of the treatment of corneal scarring caused by herpes simplex keratitis. Out of the 469 articles identified during the combined search of the literature based on the PubMed and Cochrane libraries, 10 retrospective and 2 prospective studies published from January 2010 to December 2019 were included. The study outcomes indicated that both surgical approaches resulted in a comparable improvement of visual acuity (VA). However, DALK demonstrated fewer complications in the majority of studies. Higher graft survival rates were associated with higher acyclovir (ACV) doses (above 800 mg/day), topical steroid and antibiotic drops. In conclusion, in terms of postoperative VA, both PK and DALK demonstrate comparable efficacy. However, DALK, which is applied in less severe HSK cases, is associated with fewer complications and better graft survival rates. High dosages of ACV, topical steroids and antibiotics contribute significantly to improved postoperative outcomes.

摘要

单纯疱疹病毒(HSV)在全球范围内流行。本系统评价的主要目的是比较穿透性角膜移植术(PK)和深板层角膜移植术(DALK)治疗单纯疱疹性角膜炎引起的角膜瘢痕的疗效和并发症。通过对 PubMed 和 Cochrane 图书馆的文献进行联合搜索,共确定了 469 篇文章,其中包括 2010 年 1 月至 2019 年 12 月发表的 10 篇回顾性研究和 2 篇前瞻性研究。研究结果表明,两种手术方法均能使视力(VA)得到相当程度的改善。然而,在大多数研究中,DALK 的并发症较少。较高的移植物存活率与较高的阿昔洛韦(ACV)剂量(每天 800 毫克以上)、局部皮质类固醇和抗生素滴眼液有关。总之,就术后 VA 而言,PK 和 DALK 的疗效相当。然而,DALK 适用于病情较轻的 HSK 病例,其并发症较少,移植物存活率较高。高剂量的 ACV、局部皮质类固醇和抗生素显著有助于改善术后结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验